Specialities and Expertise:Biopharma, Biotechnology, Health Care, Infectious Diseases Prevention, Recombinant Nanoparticles, Respiratory Syncytial Virus (RSV), Ebola Virus, Pandemic Influenza, Seasonal Influenza, NanoFlu, ResVax, Respiratory Syncytial Virus F-Protein Nanoparticle Vaccine, Ebola GP Vaccine, Nanoparticle Seasonal Influenza Vaccine, Infectious Disease Vaccine Candidates, SARS-CoV-2, Coronavirus, COVID-19.
Size and Minority Status
- Products and services 2
- Сommodity codes
Matrix-M adjuvant is an antibody generating proprietary technology of novavax that stimulates strong antibody and cell-mediated immune responses induced by low antigen doses.
Novavax leverages its proprietary vaccine technology to produce highly immunogenic particles to address urgent unmet medical needs.
Locations Served 2
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.